Literature DB >> 12165457

Central diabetes insipidus and inv(3)(q21q26) and monosomy 7 in acute myeloid leukemia.

Yi-Kong Keung1, David Buss, Bayard L Powell, Mark Pettenati.   

Abstract

Chromosomal anomalies involving region 3q21q26 have been reported associated with thrombocytosis in various hematological malignancies, such as chronic myeloid leukemia, myelodysplastic syndrome, and acute myeloid leukemia (AML). Recent reports described the association of central diabetes insipidus with AML and chromosomal anomalies involving region 3q21q26. We review the database in our institution and report five cases of inv(3)(q21q26) in consecutive cytogenetic studies of AML and myelodysplastic syndromes from 1992 to 2000, two cases presented as sole abnormalities and three cases were associated with monosomy 7. Only one case was associated with central diabetes insipidus. The literature of 3q21q26 syndrome and central diabetes insipidus in myeloid leukemia is reviewed.

Entities:  

Mesh:

Year:  2002        PMID: 12165457     DOI: 10.1016/s0165-4608(02)00521-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

Review 1.  Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.

Authors:  N Misaghian; G Ligresti; L S Steelman; F E Bertrand; J Bäsecke; M Libra; F Nicoletti; F Stivala; M Milella; A Tafuri; M Cervello; A M Martelli; J A McCubrey
Journal:  Leukemia       Date:  2008-09-18       Impact factor: 11.528

2.  Can a high platelet count be responsible for diabetes insipidus in acute myelogenous leukemia with monosomy 7 and inversion 3 (q21q26)?

Authors:  Mehmet Sonmez; Nergiz Erkut; T Songul Tat; Figen Celep; Umit Cobanoglu; H Onder Ersoz
Journal:  Int J Hematol       Date:  2009-08-12       Impact factor: 2.490

3.  Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2).

Authors:  Bruno C Medeiros; Holbrook E Kohrt; Daniel A Arber; Charles D Bangs; Athena M Cherry; Ravindra Majeti; Karen E Kogel; Catherine A Azar; Samit Patel; Ash A Alizadeh
Journal:  Leuk Res       Date:  2009-09-24       Impact factor: 3.156

4.  Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.

Authors:  M Rasche; C von Neuhoff; M Dworzak; J-P Bourquin; J Bradtke; G Göhring; G Escherich; G Fleischhack; N Graf; B Gruhn; O A Haas; T Klingebiel; B Kremens; T Lehrnbecher; A von Stackelberg; J Tchinda; Z Zemanova; C Thiede; N von Neuhoff; M Zimmermann; U Creutzig; D Reinhardt
Journal:  Leukemia       Date:  2017-04-25       Impact factor: 11.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.